ResearcherUniversity Medical Center UtrechtActive in the last 2 years

Madelon M. Maurice

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6885-5361; OpenAlex author ID A5044269827. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 1 paper

Papers 1

WNT7B drives a program for pancreatic cancer subtype switching and progression. Last author DOI 10.1016/j.isci.2026.115050 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Joep Sprangers · 1 shared paper, 2026 · strength 0.27
- Paper WNT7B drives a program for pancreatic cancer subtype switching and progression. DOI 10.1016/j.isci.2026.115050 ↗
Frederike Dijk · 1 shared paper, 2026 · strength 0.27
- Paper WNT7B drives a program for pancreatic cancer subtype switching and progression. DOI 10.1016/j.isci.2026.115050 ↗
Lodewijk A.A. Brosens · 1 shared paper, 2026 · strength 0.27
- Paper WNT7B drives a program for pancreatic cancer subtype switching and progression. DOI 10.1016/j.isci.2026.115050 ↗
Hans C. Clevers · 1 shared paper, 2026 · strength 0.27
- Paper WNT7B drives a program for pancreatic cancer subtype switching and progression. DOI 10.1016/j.isci.2026.115050 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.